JP2005506324A - 抗炎症剤としてのアミノピロール化合物 - Google Patents

抗炎症剤としてのアミノピロール化合物 Download PDF

Info

Publication number
JP2005506324A
JP2005506324A JP2003524985A JP2003524985A JP2005506324A JP 2005506324 A JP2005506324 A JP 2005506324A JP 2003524985 A JP2003524985 A JP 2003524985A JP 2003524985 A JP2003524985 A JP 2003524985A JP 2005506324 A JP2005506324 A JP 2005506324A
Authority
JP
Japan
Prior art keywords
disease
formula
compound
phenyl
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003524985A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005506324A5 (enExample
Inventor
ゴールドスタイン,デービッド・マイケル
ロートスタイン,デービッド・マーク
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of JP2005506324A publication Critical patent/JP2005506324A/ja
Publication of JP2005506324A5 publication Critical patent/JP2005506324A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2003524985A 2001-08-30 2002-08-26 抗炎症剤としてのアミノピロール化合物 Pending JP2005506324A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31616901P 2001-08-30 2001-08-30
PCT/EP2002/009505 WO2003020715A1 (en) 2001-08-30 2002-08-26 Aminopyrrole compounds as antiinflammatory agents

Publications (2)

Publication Number Publication Date
JP2005506324A true JP2005506324A (ja) 2005-03-03
JP2005506324A5 JP2005506324A5 (enExample) 2005-11-17

Family

ID=23227809

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003524985A Pending JP2005506324A (ja) 2001-08-30 2002-08-26 抗炎症剤としてのアミノピロール化合物

Country Status (16)

Country Link
US (1) US6696471B2 (enExample)
EP (1) EP1423378B1 (enExample)
JP (1) JP2005506324A (enExample)
KR (1) KR20040029075A (enExample)
CN (1) CN1281603C (enExample)
AR (1) AR037140A1 (enExample)
AT (1) ATE309239T1 (enExample)
AU (1) AU2002331179B2 (enExample)
BR (1) BR0212077A (enExample)
CA (1) CA2458808A1 (enExample)
DE (1) DE60207273T2 (enExample)
ES (1) ES2252509T3 (enExample)
MX (1) MXPA04001810A (enExample)
PL (1) PL373115A1 (enExample)
RU (1) RU2315045C2 (enExample)
WO (1) WO2003020715A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004060346A2 (en) 2002-12-30 2004-07-22 Angiotech International Ag Drug delivery from rapid gelling polymer composition
US20080113016A1 (en) * 2004-07-26 2008-05-15 Gary Steven Firestein Method for Prevention or Treatment of Inflammatory Disease
CA2681420A1 (en) * 2007-03-20 2008-09-25 Cadila Pharmaceuticals Limited P38 inhibitors
DK3368052T3 (da) 2015-10-27 2022-03-14 Childrens Hospital Med Ct Anvendelse af mapk-hæmmere for at nedbringe tabet af hæmatopoietiske stamceller under ex vivo-dyrkning og -genmanipulation
US20190060286A1 (en) 2016-02-29 2019-02-28 University Of Florida Research Foundation, Incorpo Chemotherapeutic Methods
ES2927715T3 (es) 2017-10-05 2022-11-10 Fulcrum Therapeutics Inc Inhibidores de la quinasa p38 reducen la expresión de dux4 y de los genes que le siguen para el tratamiento de la FSHD

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5068234A (en) * 1990-02-26 1991-11-26 Sterling Drug Inc. 3-arylcarbonyl-1-(c-attached-n-heteryl)-1h-indoles
AU3044197A (en) 1996-07-11 1998-02-09 Pfizer Inc. Pyridylpyrrole compounds useful as interleukin- and tnf antagonists
WO1998007425A1 (en) * 1996-08-21 1998-02-26 Smithkline Beecham Corporation Imidazole compounds, compositions and use
US5776954A (en) * 1996-10-30 1998-07-07 Merck & Co., Inc. Substituted pyridyl pyrroles, compositions containing such compounds and methods of use
PL344004A1 (en) 1998-05-05 2001-09-10 Hoffmann La Roche Pyrazole derivatives as p-38 map kinase inhibitors
WO1999058523A1 (en) * 1998-05-14 1999-11-18 G.D. Searle & Co. 1,5-DIARYL SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS

Also Published As

Publication number Publication date
ES2252509T3 (es) 2006-05-16
DE60207273T2 (de) 2006-07-20
DE60207273D1 (de) 2005-12-15
PL373115A1 (en) 2005-08-08
EP1423378A1 (en) 2004-06-02
EP1423378B1 (en) 2005-11-09
AR037140A1 (es) 2004-10-27
CN1547578A (zh) 2004-11-17
RU2315045C2 (ru) 2008-01-20
US6696471B2 (en) 2004-02-24
AU2002331179B2 (en) 2008-04-17
ATE309239T1 (de) 2005-11-15
US20030130319A1 (en) 2003-07-10
RU2004109817A (ru) 2005-10-20
CN1281603C (zh) 2006-10-25
MXPA04001810A (es) 2004-07-08
WO2003020715A1 (en) 2003-03-13
KR20040029075A (ko) 2004-04-03
CA2458808A1 (en) 2003-03-13
BR0212077A (pt) 2004-09-28

Similar Documents

Publication Publication Date Title
FI88504B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 4-benzyl-1-(2h)-ftalazinonderivat
KR900006853B1 (ko) 약리학적으로 활성인 피라졸로/4,3-c/피리딘의 제조방법
JPH02270874A (ja) アザビシクロ化合物及びそれらの塩、それらの製造方法、それらを含有する製薬組成物並びにそれらの薬剤としての使用
JPH0647589B2 (ja) キヌクリジン誘導体及びその組成物
HUT74090A (en) Indole derivatives, process for producing them and pharmaceutical compositions containing them
JP4740116B2 (ja) 精神疾患および神経障害の処置のための5−ht受容体アンタゴニスト
JPS58219161A (ja) 1,3−ジヒドロ−4−(1−ヒドロキシ−2−アミノエチル)−2h−インド−ル−2−オンの新誘導体、それらの塩類、それらの製造法、薬剤としての使用及びこれらを含有する組成物
JP3057095B2 (ja) イサチン誘導体、その製造方法及びその使用方法
JPH05140108A (ja) ピリジニルピペラジン誘導体
EP1423378B1 (en) Aminopyrrole compounds as antiinflammatory agents
JPS5824581A (ja) 2―オキソピリド―3―イル又はピペリジン―3―イルインドールの新誘導体及びそれらの塩、これらの製造法並びにそれらを含有する薬剤組成物
JPH02178263A (ja) アザアズレン誘導体、その製造法およびそれを有効成分とする抗アレルギー剤および抗炎症剤
JP2588977B2 (ja) ベンゼン誘導体、その調製およびこれを含有する薬学的組成物
JP3171261B2 (ja) 神経弛緩薬等としてのn−置換された3−アザビシクロ[3.2.0]ヘプタン誘導体
JPH07278148A (ja) イミダゾピラゾール誘導体
AU2002331179A1 (en) Aminopyrrole compounds as antiinflammatory agents
JP2726999B2 (ja) イミダゾ[2,1−b]ベンゾチアゾール誘導体及び該化合物を有効成分とする抗潰瘍剤
JP3694774B2 (ja) フェニルカルボン酸誘導体
JPH03163042A (ja) カルコン誘導体
HU198296B (en) Process for producing new 2-pyridyl acetic acid derivatives and pharmaceutical compositions comprising same
JPH0688999B2 (ja) ピロロ〔3,2―e〕ピラゾロ〔1,5―a〕ピリミジン誘導体およびこれを含有する医薬
JP3709203B2 (ja) 5−ht1aレセプターに対して親和性をもつ三環式化合物
JP2009519279A (ja) 三員環ラクタム誘導体、それらの製造方法、及び医薬剤としての使用
JPS6061569A (ja) 新規な3位置換アミン誘導体
JPS6352621B2 (enExample)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050805

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20090204

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090210

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090630